BE691016A - - Google Patents

Info

Publication number
BE691016A
BE691016A BE691016DA BE691016A BE 691016 A BE691016 A BE 691016A BE 691016D A BE691016D A BE 691016DA BE 691016 A BE691016 A BE 691016A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE691016A publication Critical patent/BE691016A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE691016D 1965-12-16 1966-12-12 BE691016A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1965A0051095 DE1545575C2 (de) 1965-12-16 1965-12-16 N, N'-Bis- eckige Klammer auf 3"(3', 4', 5'-trimethoxybenzoyloxy)-propyl eckige Klammer zu -homopiperazin

Publications (1)

Publication Number Publication Date
BE691016A true BE691016A (fr) 1967-06-12

Family

ID=6937763

Family Applications (1)

Application Number Title Priority Date Filing Date
BE691016D BE691016A (fr) 1965-12-16 1966-12-12

Country Status (14)

Country Link
US (1) US3532685A (fr)
AT (1) AT275527B (fr)
BE (1) BE691016A (fr)
CH (1) CH476742A (fr)
CS (1) CS191151B2 (fr)
DE (1) DE1545575C2 (fr)
DK (1) DK113291B (fr)
ES (1) ES334393A1 (fr)
FR (1) FR6053M (fr)
GB (1) GB1107470A (fr)
IL (1) IL27013A (fr)
MY (1) MY7100027A (fr)
NL (1) NL153537B (fr)
SE (1) SE317977B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980643A (en) * 1974-01-04 1976-09-14 Hokuriku Pharmaceutical Co., Ltd. Novel piperazine- and homopiperazine-monoalkanol esters and a process of production thereof
US4035494A (en) * 1975-10-20 1977-07-12 Sandoz, Inc. Bis-p-pivaloyl benzylamines
DE3403778A1 (de) * 1984-02-03 1985-08-08 Degussa Ag, 6000 Frankfurt Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin seine verwendung zur herstellung von 1-(3-hydroxy-propyl)-1,4-diazepan und 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-diazepan
JPS60258118A (ja) * 1984-06-06 1985-12-20 Kowa Co 抗動脈硬化剤
DE3438289A1 (de) * 1984-10-19 1986-04-24 Degussa Ag, 6000 Frankfurt Verfahren zum reinigen von dilazep-base
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
EP2986599A1 (fr) 2013-04-17 2016-02-24 Pfizer Inc. Dérivés de n-pipéridin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629910A (fr) * 1962-03-22
DE1182239B (de) * 1962-04-02 1964-11-26 Lentia Gmbh Verfahren zur Herstellung von Piperazinderivaten

Also Published As

Publication number Publication date
FR6053M (fr) 1968-05-20
AT275527B (de) 1969-10-27
ES334393A1 (es) 1967-11-01
IL27013A (en) 1970-07-19
DK113291B (da) 1969-03-10
DE1545575B1 (de) 1970-02-05
US3532685A (en) 1970-10-06
GB1107470A (en) 1968-03-27
CH476742A (de) 1969-08-15
DE1545575C2 (de) 1970-09-10
SE317977B (fr) 1969-12-01
NL153537B (nl) 1977-06-15
NL6617653A (fr) 1967-06-19
CS191151B2 (en) 1979-06-29
MY7100027A (en) 1971-12-31

Similar Documents

Publication Publication Date Title
FR1553822A (fr)
FR6053M (fr)
JPS449872Y1 (fr)
JPS4217299Y1 (fr)
JPS453708Y1 (fr)
JPS4425185Y1 (fr)
JPS431762Y1 (fr)
JPS4217124Y1 (fr)
NL6617324A (fr)
BE672739A (fr)
BE663771A (fr)
BE664767A (fr)
BE664900A (fr)
BE665422A (fr)
BE666175A (fr)
BE666392A (fr)
BE666856A (fr)
BE667273A (fr)
BE667886A (fr)
BE669475A (fr)
BE669636A (fr)
BE669966A (fr)
BE662956A (fr)
NL6612280A (fr)
NL6601972A (fr)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ASTA-WERKE A.G.

Effective date: 19861212